Summary
Hematometra developed in a patient recieving sequential estrogen-progestogen hormone replacement therapy following radiation for cervical carcinoma. Diagnosis, treatment and therapeutic recommendations are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barnhill D, Heller P, Dames J, Hoskins W, Gallup D, Park R (1985) Persistence of endometrial activity after radiation therapy for cervical carcinoma. Obstet Gynecol 66:805–808
Gad C (1976) Treatment and survival in 631 patients with invasive carcinoma of the cervix. Br J Obstet Gynecol 83:560–566
Gröntoft O, Risberg B, Stenson S, Westholm B (1982) Residual carcinoma after intracavitary irradiation of endometrial carcinoma, stage I. Acta Obstet Gynecol Scand 61:163–172
Sheehan JF, Schmitz HE, Towne J (1943) Changes in the uterus after eradication of endometrial adenocarcinoma by radiotherapy. Arch Pathol 39:237–240
Weinstein L (1987) Efficacy of a continuous estrogen-progestogen regimen in the menopausal patient. Obstet Gynecol 69:929–932
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sauer, M.V., Tomlinson, M. & Rich, W. Hematometra complicating hormone replacement therapy after radiation for cervical carcinoma. Arch Gynecol Obstet 243, 235–236 (1988). https://doi.org/10.1007/BF00932274
Issue Date:
DOI: https://doi.org/10.1007/BF00932274